Fair 49°
Tag:

Akiko Iwasaki

News
COVID-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine COVID-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine
Covid-19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine Some relief may be on the way for the millions of people awaiting their turn to receive the COVID-19 vaccine. Johnson & Johnson has been developing a single-dose vaccine for COVID-19, which has an efficacy rate of approximately 72 percent, potentially bringing another provider into the mix as vaccines for the virus have become a valuable and scarce commodity. If it is ultimately approved by federal health officials, the Johnson & Johnson vaccine would join Pfizer and Moderna on the market, both of which require two doses administered approximately three weeks apart. However, the ef…

SHARE

by Zak Failla